{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T23:06:58Z","timestamp":1720220818071},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","thrombosisresearch.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.thromres.2017.05.022","type":"journal-article","created":{"date-parts":[[2017,5,25]],"date-time":"2017-05-25T06:45:26Z","timestamp":1495694726000},"page":"8-13","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Feasibility of the Von Willebrand disease PREVENT trial"],"prefix":"10.1016","volume":"156","author":[{"given":"Margaret V.","family":"Ragni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicoletta","family":"Machin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andra H.","family":"James","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig D.","family":"Seaman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynn M.","family":"Malec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig M.","family":"Kessler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara A.","family":"Konkle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter A.","family":"Kouides","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne T.","family":"Neff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire S.","family":"Philipp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria M.","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2017.05.022_bb0005","doi-asserted-by":"crossref","first-page":"11651","DOI":"10.1111\/j.1538-7836.2007.02563.x","article-title":"Bleeding events and other complications during pregnancy and childbirth in women with von Willebrand disease","volume":"5","author":"James","year":"2007","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2017.05.022_bb0010","doi-asserted-by":"crossref","first-page":"e442","DOI":"10.1111\/hae.12739","article-title":"Postpartum hemorrhage in women with von Willebrand disease: an observational study of the Pennsylvania Health Care Cost Containment Council (PHC4) database","volume":"21","author":"Malec","year":"2015","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2017.05.022_bb0015","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1046\/j.1365-2516.1999.00342.x","article-title":"von Willebrand disease and bleeding in women","volume":"5","author":"Ragni","year":"1999","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2017.05.022_bb0020","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1538-7836.2005.01150.x","article-title":"von Willebrand disease and pregnancy","volume":"3","author":"Kujovich","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2017.05.022_bb0025","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S1701-2163(16)30551-5","article-title":"Gynaecological and obstetric management of women with inherited bleeding disorders","volume":"27","author":"Demers","year":"2005","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"10.1016\/j.thromres.2017.05.022_bb0030","doi-asserted-by":"crossref","first-page":"e562","DOI":"10.1111\/hae.13086","article-title":"A prospective study of von Willebrand factor levels and bleeding in pregnant women with type 1 von Willebrand disease","volume":"22","author":"Sood","year":"2016","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2017.05.022_bb0035","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/hae.12568","article-title":"Postpartum von Willebrand factor levels in women with and without von Willebrand disease and implications for prophylaxis","volume":"21","author":"James","year":"2015","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2017.05.022_bb0040","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/hae.12635","article-title":"Primary postpartum haemorrhage in women with von Willebrand disease or carriership of haemophilia despite specialized care: a retrospective survey","volume":"4","author":"Stoof","year":"2015","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2017.05.022_bb0045","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2516.2007.01643.x","article-title":"Von Willebrand disease: Evidence-based diagnosis and management guidelines, the National Heart, Lung, and blood Institute (NHLBI) Expert Panel Report (USA)","volume":"14","author":"Nichols","year":"2008","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2017.05.022_bb0050","first-page":"117","article-title":"Evidence-based recommendations on the treatment of von Willebrand disease in Italy","volume":"7","author":"Mannucci","year":"2009","journal-title":"Blood Transfus."},{"key":"10.1016\/j.thromres.2017.05.022_bb0055","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/bjh.13064","article-title":"The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology","volume":"167","author":"Laffan","year":"2014","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2017.05.022_bb0060","series-title":"National Hemophilia Foundation. MASAC Guidelines for Perinatal Management of Women With Bleeding Disorders and Carriers of Hemophilia A and B","year":"2009"},{"key":"10.1016\/j.thromres.2017.05.022_bb0065","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1182\/blood.V90.7.2515","article-title":"Desmopressin in the treatment of bleeding disorders: the first 20years","volume":"90","author":"Mannucci","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2017.05.022_bb0070","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1046\/j.1365-2516.1999.00313.x","article-title":"Desmopressin in the treatment of women's bleeding disorders","volume":"5","author":"Lethagen","year":"1999","journal-title":"Haemophilia"},{"issue":"Suppl. 1","key":"10.1016\/j.thromres.2017.05.022_bb0075","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1160\/TH16-01-0050","article-title":"Contemporary issue in the management of von Willebrand disease","volume":"116","author":"Federici","year":"2016","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2017.05.022_bb0080","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/MBC.0b013e3283254570","article-title":"Von Willebrand factor\/factor VIII concentrates in the treatment of von Willebrand disease","volume":"20","author":"Batlle","year":"2009","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.thromres.2017.05.022_bb0085","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1471-0528.1963.tb04922.x","article-title":"Increase in plasma volume during normal pregnancy","volume":"70","author":"Hytten","year":"1963","journal-title":"J. Obstet. Gynecol. Br. Emp."},{"key":"10.1016\/j.thromres.2017.05.022_bb0090","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0308-2261(21)00496-3","article-title":"Blood volume changes in normal pregnancy","volume":"14","author":"Hytten","year":"1985","journal-title":"Clin. Haematol."},{"key":"10.1016\/j.thromres.2017.05.022_bb0095","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/cvr\/cvu009","article-title":"Maternal cardiac metabolism in pregnancy","volume":"101","author":"Liu","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.thromres.2017.05.022_bb0100","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/0002-9378(89)90900-9","article-title":"Central hemodynamic assessment of normal term pregnancy","volume":"161","author":"Clark","year":"1989","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"Suppl. 4","key":"10.1016\/j.thromres.2017.05.022_bb0105","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-2516.2006.01332.x","article-title":"Pharmacokinetic studies of coagulation factors: relevance of plasma and extracellular volume and body weight","volume":"12","author":"Komwilaisak","year":"2006","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2017.05.022_bb0110","first-page":"612","article-title":"Population pharmacokinetics of recombinant factor VIII: the relationships of pharmacokinetics to age and body weight","volume":"119","author":"Bj\u00f6rkman","year":"2012","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2017.05.022_bb0115","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1055\/s-0030-1255445","article-title":"Structure and function of a recombinant von Willebrand factor drug candidate","volume":"36","author":"Turecek","year":"2010","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2017.05.022_bb0120","first-page":"237","article-title":"Clinical trial opportunities in Hemostasis and thrombosis. Proceedings of the NHLBI State-of-the-Science Symposium","volume":"87","author":"Cines","year":"2012","journal-title":"Am. J. Med."},{"key":"10.1016\/j.thromres.2017.05.022_bb0125","first-page":"734","article-title":"Assessment of menstrual blood loss using a pictorial chart","volume":"97","author":"Higham","year":"1990","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2017.05.022_bb0130","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1471-0528.2000.tb13225.x","article-title":"Assessment of menstrual blood loss using a pictorial chart: a validation study","volume":"107","author":"Reid","year":"2000","journal-title":"BJOG"},{"key":"10.1016\/j.thromres.2017.05.022_bb0135","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/BF01836069","article-title":"Pharmacokinetics and hemostatic effect of different factor VIII\/von Willebrand factor concentrates in von Willebrand disedase type III","volume":"65","author":"Lethagan","year":"1992","journal-title":"Ann. Hematol."},{"issue":"Suppl. 3","key":"10.1016\/j.thromres.2017.05.022_bb0140","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1046\/j.1365-2516.1998.0040s3048.x","article-title":"Clinical management of patients with von Willebrand disease with a VHP VWF concentrate: the French experience","volume":"4","author":"Goudemand","year":"1998","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2017.05.022_bb0145","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1055\/s-0037-1612977","article-title":"Efficacy and safety of the factor VIII\/von Willebrand factor concentrate, haemate-P\/humate-P: ristocetin cofactor unit dosing in patients with von Willebrand disease","volume":"87","author":"Lillicrap","year":"2002","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2017.05.022_bb0150","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1182\/blood.V99.2.450","article-title":"Treatment of von Willebrand disease with a high-purity factor VIII\/von Willebrand factor concentrate: a prospective multicenter study","volume":"15","author":"Mannucci","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2017.05.022_bb0155","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1046\/j.1351-8216.2003.00816.x","article-title":"Successful treatment of urgent bleeding in von Willebrand disease with factor VIII\/VWF concentrate (Humate P): use of the ristocetin cofactor assay (VWF:RC0) to measure potency and to guide therapy","volume":"9","author":"Gill","year":"2003","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2017.05.022_bb0160","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1111\/j.1538-7836.2005.01435.x","article-title":"Pharmacokinetic studies on Wilfactin, a von Willebrand factor concentrates with a low factor VIII level content treated with three virus inactivation\/removal methods","volume":"3","author":"Goudemand","year":"2005","journal-title":"J. Thromb. Haemost."},{"issue":"Suppl. 5","key":"10.1016\/j.thromres.2017.05.022_bb0165","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2516.2007.01573.x","article-title":"Highly purified VWF\/FVIII concentrates in the treatment and prophylaxis of von Willebrand disease: the PRO.WILL Study","volume":"13","author":"Federici","year":"2007","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2017.05.022_bb0170","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1111\/j.1538-7836.2007.02588.x","article-title":"Von Willebrand factor\/factor VIII concentrate (Haemate P) dosing based on pharmacokinetics: a prospective multicenter trial in elective surgery","volume":"5","author":"Lethagan","year":"2007","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2017.05.022_bb0175","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/j.1365-2516.2011.02534.x","article-title":"von Willebrand factor\/factor VIII concentrate (Humate-P) for management of elective surgery in adults and children with von Willebrand disease","volume":"17","author":"Gill","year":"2011","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2017.05.022_bb0180","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1160\/TH11-02-0057","article-title":"The pharmacokinetic diversity of two von Willebrand factor (VWF\/factor VIII (FVIII)) concentrates in subjects with congenital von Willebrand disease: results from a prospective, randomized crossover study","volume":"106","author":"Kessler","year":"2011","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2017.05.022_bb0185","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1182\/blood-2013-01-479527","article-title":"Pharmacokinetics and safety of a novel recombinant human von Willebrand factor manufactured with a plasma-free method: a multicenter prospective clinical trial","volume":"122","author":"Mannucci","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2017.05.022_bb0190","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/hae.12237","article-title":"Efficacy and safety of Wilate in paediatric VWD patients under 6 years of age \u2014 results of a prospective multicenter clinical study including recovery information","volume":"19","author":"Nowak G\u00f6tl","year":"2013","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2017.05.022_bb0195","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1182\/blood-2015-02-629873","article-title":"Hemostatic efficacy, safety, and pharmacokinetics of a recombinant von Willebrand factor in patients with severe von Willebrand disease","volume":"126","author":"Gill","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2017.05.022_bb0205","series-title":"Personal Communication","year":"2017"},{"key":"10.1016\/j.thromres.2017.05.022_bb0215","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0140-6736(95)90166-3","article-title":"Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep vein thrombosis","volume":"345","author":"Koster","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2017.05.022_bb0220","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2165\/00003088-200544100-00001","article-title":"Pregnancy-induced changes in pharmacokinetics","volume":"44","author":"Anderson","year":"2005","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.thromres.2017.05.022_bb0225","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2174\/138920009788897993","article-title":"Variation of drug kinetics in pregnancy","volume":"10","author":"Pavek","year":"2009","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.thromres.2017.05.022_bb0230","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2165\/00003088-200948030-00002","article-title":"Effect of pregnancy on the pharmacokinetics of antihypertensive drugs","volume":"48","author":"Anderson","year":"2010","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.thromres.2017.05.022_bb0235","unstructured":"Medical product safety. In Healthy People 2020, Accessed August 6, 2016, http:\/\/www.healthypeople.gov\/2020\/topics-objectives\/blood-disorders-and-blood-safety."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384817303407?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384817303407?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T18:43:40Z","timestamp":1692816220000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384817303407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":45,"alternative-id":["S0049384817303407"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2017.05.022","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Feasibility of the Von Willebrand disease PREVENT trial","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2017.05.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}